Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lessons from aviation safety: pilot monitoring, the sterile flight deck rule, and aviation-style computerised checklists in the operating room.

British journal of anaesthesia·2023
Same author

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific.

Annals of neurology·2023
Same author

Integrative analysis of multi-omics and imaging data with incorporation of biological information via structural Bayesian factor analysis.

Briefings in bioinformatics·2023
Same author

Preference Matrix Guided Sparse Canonical Correlation Analysis for Genetic Study of Quantitative Traits in Alzheimer's Disease.

Proceedings. IEEE International Conference on Bioinformatics and Biomedicine·2023
Same author

Multi-task deep autoencoder to predict Alzheimer's disease progression using temporal DNA methylation data in peripheral blood.

Computational and structural biotechnology journal·2023
Same author

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins.

Molecular neurodegeneration·2023
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Akira A Nair1, Zixuan Wen1, Zexuan Wang1

  • 1University of Pennsylvania, Philadelphia, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

阿尔茨海默病的进展可以使用粉样β斑块,神经纤维状结和神经元损失生物标志物分阶段. 像PHATE,Slingshot和SuStaIn这样的计算方法揭示了这些生物标志物的独特但融合的轨迹,有助于疾病预测.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 计算生物学 计算生物学

背景情况:

  • 阿尔茨海默病 (AD) 的特点是粉样β斑块 (A),神经纤维状结 (T) 和神经元损失 (N),统称为A/T/N.
  • 了解神经退行症的空间进展对于预测AD轨迹和结果至关重要.

研究的目的:

  • 使用A/T/N生物标志物探索AD患者的病期和伪时间.
  • 利用来自阿尔茨海默病神经成像计划 (ADNI) 的 pozitron发射断层扫描 (PET) 和磁共振成像 (MRI) 数据.

主要方法:

  • 应用PHATE来减少维度,以可视化A/T/N模式的疾病进展轨迹.
  • 使用Slingshot将PHATE嵌入式转换为1D伪时间值.
  • 使用SuStaIn,一种机器学习算法,来预测患者的病期和生物标志物序列.
  • 将SustaIn阶段的预测与PHATE/Slingshot伪时值进行比较,以评估强度.

主要成果:

  • 在所有模式中,SuStaIn预测的阶段与PHATE/Slingshot伪时值密切结合.
  • 粉样蛋白PET和蛋白PET显示出比基于MRI的体积更强的轨迹对齐.
  • 来自SustaIn的生物标志物事件序列与PHATE伪时间告知模型一致.
  • 粉样和形态表现出中度的伪物质时间相关性,但不同的驱动生物标志物事件.

结论:

  • 对计算方法的综合分析提高了对疾病进展时间的信心.
  • 粉样蛋白和蛋白生物标志物似乎遵循不同的皮质轨迹.
  • 不同的计算方法独立地产生了关于疾病进展的类似发现.